Neoplasms, Hematologic Completed Phase 2 Trials for Pegfilgrastim (DB00019)

Also known as: Hematological Neoplasm / Hematological Neoplasms / Hematologic Neoplasm / Hematologic Neoplasms / Haematological neoplasm / Malignant tumor of lymphoid hemopoietic and related tissue (disorder) / Haematological malignancy / Hematological malignancy / Hematologic neoplasm (disorder)

IndicationStatusPhase
DBCOND0056760 (Neoplasms, Hematologic)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00410696Pegfilgrastim Versus Filgrastim After High-dose ChemotherapyTreatment